High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome

Metabolism: Clinical and Experimental

Volumn 55, Issue 8, 2006, Pages 1014-1021

  Aso, Yoshimasa ^a   Wakabayashi, Sadao ^a   Nakano, Tomoki ^a   Yamamoto, Ruriko ^a   Takebayashi, Kohzo ^a   Inukai, Toshihiko ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR SYSTEM; CHOLINERGIC SYSTEM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EDUCATION PROGRAM; FEMALE; FOURIER TRANSFORMATION; HEART; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; POWER SPECTRUM; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SPECTROSCOPY; SYMPATHETIC TONE; URINALYSIS; VAGUS NERVE STIMULATION;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; C-REACTIVE PROTEIN; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEART RATE; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REGRESSION ANALYSIS; SEX CHARACTERISTICS; SYMPATHETIC NERVOUS SYSTEM; TRIGLYCERIDES; VAGUS NERVE;

EID: 33745885021     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.03.011     Document Type: Article

References (47)

1. Liao D., Carnethon M., Evans G.W., Cascio W.E., and Heiss G. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes 51 (2002) 3524-3531
2. Liao D., Sloan R.P., Cascio W.E., Folsom A.R., Liese A.D., Evans G.W., et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 21 (1998) 2116-2122
3. Wheeler T., and Watkins P.J. Cardiac denervation in diabetes. Br J Med 4 (1973) 584-586
4. Pagani M., Lombardi F., Guzzetti S., Rimoldi O., Furlan R., Pizzinelli P., et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 59 (1986) 178-193
5. Eckberg D.L. Sympathovagal balance: a critical appraisal. Circulation 96 (1997) 3224-3232
6. Spallone V., Bernardi L., Ricordi L., Solda P., Maiello M.R., Calciati A., et al. Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. Diabetes 42 (1993) 1745-1752
7. Muller J.E., Stone P.H., Turi Z.G., Rutherford J.D., Czeisler C.A., Parker C., et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 313 (1985) 1315-1322
8. Pikkujamsa S.M., Huikuri H.V., Airaksinen K.E., Rantala A.O., Kauma H., Lilja M., et al. Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome. Am J Hypertens 11 (1998) 523-531
9. Brunner E.J., Hemingway H., Walker B.R., Page M., Clarke P., Juneja M., et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 106 (2002) 2659-2665
10. Laaksonen D.E., Laitinen T., Schonberg J., Rissanen A., and Niskanen L.K. Weight loss and weight maintenance, ambulatory blood pressure and cardiac autonomic tone in obese persons with the metabolic syndrome. J Hypertens 21 (2003) 371-378
11. Kang M.G., Koh S.B., Cha B.S., Park J.K., Woo J.M., and Chang S.J. Association between job stress on heart rate variability and metabolic syndrome in shipyard male workers. Yonsei Med J 45 (2004) 838-846
12. Hemingway H., Shipley M., Brunner E., Britton A., Malik M., and Marmot M. Does autonomic function link social position to coronary risk? The Whitehall II study. Circulation 111 (2005) 3071-3077
13. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
14. DeFronzo R.A., and Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 (1991) 173-194
15. Resnick H.E., Jones K., Ruotolo G., Jain A.K., Henderson J., Lu W., et al. Strong Heart Study. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diabetes Care 26 (2003) 861-867
16. Malik S., Wong N.D., Franklin S.S., Kamath T.V., L'Italien G.J., Pio J.R., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250
17. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
18. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
19. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
20. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., et al. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) investigators. C-Reactive protein levels and outcomes after statin therapy. N Engl J Med 352 (2005) 20-28
21. Lemieux I., Pascot A., Prud'homme D., Almeras N., Bogaty P., Nadeau A., et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 21 (2001) 961-967
22. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-Reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
23. Riediker M., Cascio W.E., Griggs T.R., Herbst M.C., Bromberg P.A., Neas L., et al. Particulate matter exposure in cars is associated with cardiovascular effects in healthy young men. Am J Respir Crit Care Med 169 (2004) 934-940
24. Pope III C.A., Hansen M.L., Long R.W., Nielsen K.R., Eatough N.L., Wilson W.E., et al. Ambient particulate air pollution, heart rate variability, and blood markers of inflammation in a panel of elderly subjects. Environ Health Perspect 112 (2004) 339-345
25. Sajadieh A., Nielsen O.W., Rasmussen V., Hein H.O., Abedini S., and Hansen J.F. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 25 (2004) 363-370
26. Parish J.M., and Somers V.K. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 79 (2004) 1036-1046
27. Janszky I., Ericson M., Lekander M., Blom M., Buhlin K., Georgiades A., et al. Inflammatory markers and heart rate variability in women with coronary heart disease. J Intern Med 256 (2004) 421-428
28. Shehab A.M., MacFadyen R.J., McLaren M., Tavendale R., Belch J.J., and Struthers A.D. Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study. Heart 90 (2004) 1263-1268
29. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NC EP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
30. Reaven G.M. The metabolic syndrome: requiescat in pace. Clin Chem 51 (2005) 931-938
31. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
32. Wakabayashi S., and Aso Y. Adiponectin concentrations in sera from patients with type 2 diabetes are negatively associated with sympathovagal balance as evaluated by power spectral analysis of heart rate variation. Diabetes Care 27 (2004) 2392-2397
33. Matsuzawa Y., Funahashi T., Kihara S., and Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24 (2004) 29-33
34. Alvarez G.E., Beske S.D., Ballard T.P., and Davy K.P. Sympathetic neural activation in visceral obesity. Circulation 106 (2002) 2533-2536
35. Muscelli E., Emdin M., Natali A., Pratali L., Camastra S., Gastaldelli A., et al. Autonomic and hemodynamic responses to insulin in lean and obese humans. J Clin Endocrinol Metab 83 (1998) 2084-2090
36. Freeman D.J., Norrie J., Caslake M.J., Gaw A., Ford I., Lowe G.D., et al. C-Reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51 (2002) 1596-1600
37. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., Lenfant C., and American Heart Association. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
38. Shuldiner A.R., Yang R., and Gong D.W. Resistin, obesity and insulin resistance-the emerging role of the adipocyte as an endocrine organ. N Engl J Med 345 (2001) 1345-1346
39. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
40. Anan F., Takahashi N., Nakagawa M., Ooie T., Saikawa T., and Yoshimatsu H. High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Metabolism 54 (2005) 552-558
41. Aso Y., Fujiwara Y., Inukai T., and Takemura Y. Power spectral analysis of heart rate variation in diabetic patients with neuropathic foot ulceration. Diabetes Care 21 (1998) 1173-1177
42. Marfella R., Gualdiero P., Siniscalchi M., Carusone C., Verza M., Marzano S., et al. Morning blood pressure peak, QT intervals, and sympathetic activity in hypertensive patients. Hypertension 41 (2003) 237-243
43. Bigger J.T., Fleiss J.L., Rolnitzky L.M., and Steinman R.C. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation 88 (1993) 927-934
44. Liao D., Barnes R.W., Chambless L.E., Simpson Jr. R.J., Sorlie P., and Heiss G. Age, race, and sex differences in autonomic cardiac function measured by spectral analysis of heart rate variability-the ARIC study. Atherosclerosis Risk in Communities. Am J Cardiol 76 (1995) 906-912
45. Huikuri H.V., Pikkujamsa S.M., Airaksinen K.E., Ikaheimo M.J., Rantala A.O., Kauma H., et al. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation 94 (1996) 122-125
46. Kuo T.B., Lin T., Yang C.C., Li C.L., Chen C.F., and Chou P. Effect of aging on gender differences in neural control of heart rate. Am J Physiol 277 (1999) H2233-H2239
47. Umetani K., Singer D.H., McCraty R., and Atkinson M. Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. J Am Coll Cardiol 31 (1998) 593-601